TP53 and serous adenocarcinoma: Epithelial ovarian tumors were separated according to TP53’s status, either wild-type (likely a mixture of low-grade tumors; 145 patients) or aberrant (high-grade serous carcinomas (HGSC); 161 patients, see Fig. 7A).